Gabapentin
- Product NDC
- 50268-325
- 11-digit product format
- 502680325
- Labeler code
- 50268
- Product ID
- 50268-325_2b4c1c97-dc71-3801-e063-6394a90a7faf
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- AvPAK
- Application
- ANDA207057
- Marketing category
- ANDA
- Marketing start
- 2023-05-01
- Substance
- GABAPENTIN
- Active strength
- 600 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 6CW7F3G59X | GABAPENTIN | 60142-96-3 | GABAPENTIN |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50268-325-15 | 50268032515 | 50 BLISTER PACK in 1 BOX (50268-325-15) / 1 TABLET, COATED in 1 BLISTER PACK (50268-325-11) | 50 blister pack | 2023-05-01 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Gabapentin | AvPAK | 2025-01-09 | HUMAN PRESCRIPTION DRUG LABEL | 2 |